Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
AM-694
AM-694 is a synthetic cannabinoid in the benzoylindole chemical class1, categorized as a cannabinoid.2 It was first reported to the EMCDDA by Irish authorities in July 2010 after detection in the herbal smoking product Shamrock1, after the original Spice products declined. Reported preparations were psychoactive but less intense and apparently more benign than earlier synthetic cannabinoids, although this characterization comes from limited personal sampling. Effects were anticipated to last about two hours.
Dosage & Duration
Duration
Subjective Effects
Pharmacology
Pharmacodynamics
AM-694 is a potent cannabinoid receptor agonist with strong selectivity for CB1. It binds CB1 with a Ki of 0.08 nM3 and CB2 with a Ki of 1.44 nM3, corresponding to approximately 18-fold selectivity for CB1 over CB2.4 This receptor profile has supported its use as a research ligand for mapping CB1 distribution.
Pharmacokinetics
Reported metabolic pathways include hydrolytic defluorination, carboxylation, and monohydroxylation of the N-alkyl chain5. Some reports suggest that oral consumption may produce fluoroacetic acid through metabolism.
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
Toxicity
Oral administration may produce the highly toxic metabolite fluoroacetic acid, posing significant systemic toxicity risk; this route of administration should be strictly avoided.
History & Culture
Products containing AM-694 spread while still legal after Italy prohibited the manufacture, import, and sale of products such as Spice and n-Joy in April 2010 and listed JWH-018 and JWH-073 as illegal in July 2010.6 AM-694 was also used in scientific research to map the distribution of CB1 receptors in the body.
Legality
By Country
References
Source Pages
Citations
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed: this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the AM-694 article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.